On September 14th, RudaCure held a briefing session for accionistas to provide an update on recent logros and current business activities, and to foster mutual understanding and continued cooperación.
We thank the accionistas who asistió, and we will maintain our shareholder-first management approach based on the information discutió and shared on the day, while doing our utmost to achieve our desarrollo de fármacos goals.
We hope you will continue to watch RudaCure grow and cheer us on.
Gracias.